前交叉韧带断裂增加尿液NTX-I、CTX-II及血清ARGS-aggrecan、TNF-α水平
该描述性实验室研究对比了152例近期前交叉韧带断裂患者与健康膝关节对照者的生物标志物水平,并随访2年。伤后中位11周时血清ARGS-aggrecan和TNF-α升高1.5倍,尿NTX-I和CTX-II分别升高1.3倍和3.7倍,且CTX-II在2年随访时仍高于对照。
要点
- 前交叉韧带断裂后早期即可检测到软骨和骨代谢标志物升高。
- 尿CTX-II在伤后2年仍高于健康对照,提示持续软骨降解。
- 血清ARGS-aggrecan、尿NTX-I与尿CTX-II之间呈强相关。
核心结论
- 前交叉韧带断裂后数月内血清ARGS-aggrecan、TNF-α及尿NTX-I、CTX-II水平可测量性升高,且2年随访时仍高于健康对照。
研究设计与样本
- 描述性实验室研究,纳入152例急性前交叉韧带断裂患者,中位年龄25岁(IQR 21-32岁)。
- 在入组时(伤后3-25周)及伤后14、27个月采集血清和尿液样本,并设健康膝关节对照。
主要发现
- 伤后中位11周(IQR 7-17周)血清ARGS-aggrecan和TNF-α较对照升高1.5倍(P < .001),随访中呈时间依赖性下降。
- 伤后早期尿NTX-I和CTX-II分别较对照升高1.3倍(P < .001)和3.7倍(P < .001)。
- 尿CTX-II在2年随访时仍高于对照。
- 血清ARGS-aggrecan、尿NTX-I与尿CTX-II之间呈强相关(rs = 0.57-0.68)。
临床怎么用
- 对于前交叉韧带断裂患者,可关注上述生物标志物以评估伤后软骨和骨代谢变化。
- 尿CTX-II持续升高提示伤后2年内仍存在软骨降解活动,支持早期干预监测。
局限性
- 本研究为描述性实验室研究,样本采集时间窗较宽(伤后3-25周)。
- 血清对照样本仅26例,年龄中位数35岁,与患者组25岁存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An anterior cruciate ligament (ACL) rupture results in an increased risk of developing knee osteoarthritis (OA) at an early age. Before clinical signs become apparent, the OA process has already been initiated. Therefore, it is important to look at the cascade of changes, such as the activity of cytokines and proteases, which might be associated with the later development of OA. PURPOSE: To compare biomarker levels in patients with a recent ACL rupture with those in controls with a healthy knee and to monitor biomarker levels over 2 years after an ACL rupture. STUDY DESIGN: Descriptive laboratory study. METHODS: Patients were enrolled after an ACL tear was identified. Serum and urine samples were collected at the time of enrollment in the study (3-25 weeks after the injury) and then at 14 and 27 months after the injury between January 2009 and November 2010. Reference samples were obtained from participants with healthy knees. The following biomarkers were measured with immunological assays: aggrecan ARGS neoepitope (ARGS-aggrecan), tumor necrosis factor-α (TNF-α), interferon-γ, interleukin (IL)-8, IL-10, IL-13, N-terminal cross-linked telopeptide of type I collagen (NTX-I), and C-terminal cross-linked telopeptide of type II collagen (CTX-II). RESULTS: Samples were collected from 152 patients with an acute ACL rupture, who had a median age of 25 years (interquartile range [IQR], 21-32 years). There were 62 urine reference samples (median age, 25 years [IQR, 22-36 years]) and 26 serum reference samples (median age, 35 years [IQR, 24-39 years]). At a median of 11 weeks (IQR, 7-17 weeks) after trauma, serum levels of both ARGS-aggrecan and TNF-α were elevated 1.5-fold (P < .001) compared with reference samples and showed a time-dependent decrease during follow-up. Urine NTX-I and CTX-II concentrations were elevated in an early phase after trauma (1.3-fold [P < .001] and 3.7-fold [P < .001], respectively) compared with reference samples, and CTX-II levels remained elevated compared with reference samples at 2-year follow-up. Strong correlations were found between serum ARGS-aggrecan, urinary NTX-I, and urinary CTX-II (rs = 0.57-0.68). CONCLUSION: In the first few months after an ACL injury, there was a measurable increase in serum levels of ARGS-aggrecan and TNF-α as well as urine levels of NTX-I and CTX-II. These markers remained high compared with those of controls with healthy knees at 2-year follow-up.
引用
- Hagemans FJA, Larsson S, Reijman M, et al. An Anterior Cruciate Ligament Rupture Increases Levels of Urine N-terminal Cross-linked Telopeptide of Type I Collagen, Urine C-terminal Cross-linked Telopeptide of Type II Collagen, Serum Aggrecan ARGS Neoepitope, and Serum Tumor Necrosis Factor-α. Am J Sports Med. 2021. PMID: 34591687. doi:10.1177/03635465211042310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。